⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

TRLV

Trulieve Cannabis Corp.

Healthcare · Drug Manufacturers - Specialty & Generic

10.42USD

-0.5000 (-4.58%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on TRLV.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$0.07▲$0.0310
Next quarter$0.08▲$0.0410
Current year-$1.82▼$0.2103
Next year$0.56▲$0.2410

Recent quarters

Beat in 3 of the last 4

QuarterEstimateActualSurprise
2026-06-30$0.03$0.11+0.08 (+266.7%)
2026-03-31-$0.05$0.1+0.15 (+300.0%)
2025-12-31-$0.03-$0.02+0.01 (+31.0%)
2025-09-30-$0.07-$0.07-0.00 (-3.3%)

Wall Street coverage

3 ratings from 1 firm

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
Cantor FitzgeraldReiteratedOverweight$15Oct 23, 2026
Cantor FitzgeraldReiteratedOverweight$15Aug 7, 2026
Cantor FitzgeraldInitiatedOverweight$15Jul 20, 2026

Insider transactions

49 filings from 21 insiders · 112 buy / 4 sell over 6m

Officers and directors of TRLV, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
RIVERS KIMBERLY AChief Executive OfficerSell136.8k$8.76$1.20MJun 26, 2026
RIVERS KIMBERLY AChief Executive OfficerSell1.08M$8.17$8.94MJun 25, 2026
RIVERS KIMBERLY AChief Executive OfficerSell482.2k$9.35$4.53MJun 22, 2026
MORREAU JANE CECILDirectorOther23.4k——Mar 13, 2026
THRONSON SUSAN EDirectorOther23.4k——Mar 13, 2026
FOULSTON MATTHEW JOHNDirectorOther23.4k——Mar 13, 2026
BESHEARS THADDirectorOther23.4k——Mar 13, 2026
POWERS RAYMOND ERIC IIIOfficerOther58.6k——Mar 13, 2026
LANDRUM KYLE FINNOfficerOther58.6k——Mar 13, 2026
RIVERS KIMBERLY AChief Executive OfficerOther218.8k——Mar 13, 2026
MAY RICHARD SUBERDirectorOther23.4k——Mar 13, 2026
HEALY PETER THOMASDirectorOther23.4k——Mar 13, 2026
JHALA NILYUMChief Technology OfficerOther58.6k——Mar 13, 2026
PERNELL JASON BARRYPresidentOther58.6k——Mar 13, 2026
REESE JANChief Financial OfficerOther58.6k——Mar 13, 2026
HERSEY CHRISTINE ANNOfficerOther58.6k——Mar 13, 2026
WALSH BRETTOfficerOther28.7k——Mar 13, 2026
MILLNER THOMAS LDirectorOther23.4k——Mar 13, 2026
RIVERS KIMBERLY AChief Executive OfficerOther820.0k——Mar 3, 2026
FOULSTON MATTHEW JOHNDirectorOther11.3k——Nov 4, 2025

Analyst Notes

Sign in to write

No analyst notes on TRLV yet.

Analyst Ratings

7 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current16000Buy1.86
1 mo ago16000Buy1.86
2 mo ago16000Buy1.86
3 mo ago16000Buy1.86
Price target$18.18$15.00 – $21.00
+74.5% to target

Top voices on TRLV

Members whose judged calls on TRLV have played out most reliably.

No settled calls on TRLV yet. Nobody has filed a call with a deadline on it.

A member is listed once they have three judged calls on a name.

Sign in to make a call

A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.

A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.

A member’s prediction, judged on price history · not investment advice